Drug Resistance Genotypes Predict Response to Amprenavir-Containing Regimens in Highly Drug-Experienced HIV-1-Infected Patients
Caroline Sabin(Primary Health Care), Deenan Pillay(Public Health England), Emmanuel Vlahakis, Philippa Easterbrook(World Health Organization), Clifford Leen, Li Xu(Heartlands Hospital), Patricia A. Cane(University of Birmingham), Maurice Murphy(Royal London Hospital), Annemiek de Ruiter(ViiV Healthcare (Spain)), Ed Wilkins, Martin Fisher(Northwell Health)
Cited by 0
Related Papers
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
|The Journal of Experimental Medicine|2000|864